enow.com Web Search

  1. Ads

    related to: paroxysmal nocturnal hemoglobinuria pnh symptoms

Search results

  1. Results from the WOW.Com Content Network
  2. Paroxysmal nocturnal hemoglobinuria - Wikipedia

    en.wikipedia.org/wiki/Paroxysmal_nocturnal...

    Danicopan, sold under the brand name Voydeya, is a medication used for the treatment of paroxysmal nocturnal hemoglobinuria. It is a complement inhibitor which reversibly binds to factor D to prevent alternative pathway-mediated hemolysis and deposition of complement C3 proteins on red blood cells. The most common side effects include fever, headache, increased levels of liver enzymes (a sign ...

  3. Paroxysmal attack - Wikipedia

    en.wikipedia.org/wiki/Paroxysmal_attack

    They are usually associated with multiple sclerosis or pertussis, but they may also be observed in other disorders such as encephalitis, head trauma, stroke, autism, asthma, trigeminal neuralgia, breath-holding spells, epilepsy, malaria, tabes dorsalis, and Behçet's disease, paroxysmal nocturnal hemoglobinuria (PNH).

  4. Sucrose lysis test - Wikipedia

    en.wikipedia.org/wiki/Sucrose_lysis_test

    The sucrose lysis test is a diagnostic laboratory test used for diagnosing paroxysmal nocturnal hemoglobinuria (PNH), as well as for hypoplastic anemias and any hemolytic anemia with an unclear cause. [1] The test works by using sucrose, which creates a low ionic strength environment that allows complement to bind to red blood cells. [1]

  5. Decay-accelerating factor - Wikipedia

    en.wikipedia.org/wiki/Decay-accelerating_factor

    Because DAF is a GPI-anchored protein, its expression is reduced in persons with mutations that reduce GPI levels such as those with paroxysmal nocturnal hemoglobinuria (PNH). In PNH disorder, red blood cells with very low levels of DAF and CD59 undergo complement-mediated hemolysis. Symptoms include low red blood cell count (anemia), fatigue ...

  6. US FDA approves Roche's drug for a chronic blood disorder ...

    www.aol.com/news/us-fda-approves-roches-drug...

    The drug crovalimab, branded as PiaSky, is a monthly under-the-skin or intravenous treatment for paroxysmal nocturnal hemoglobinuria (PNH). PNH is a disorder in which red blood cells break apart ...

  7. Hemolytic anemia - Wikipedia

    en.wikipedia.org/wiki/Hemolytic_anemia

    Paroxysmal nocturnal hemoglobinuria (PNH), sometimes referred to as Marchiafava-Micheli syndrome, is a rare, acquired, potentially life-threatening disease of the blood characterized by complement-induced intravascular hemolytic anemia. [19] Lead poisoning resulting from the environment causes non-immune hemolytic anemia. [20]

  8. References. 1. Hill A, Kelly R, Kulasekararaj A, et al. Eculizumab in paroxysmal nocturnal hemoglobinuria (PNH): a report of all 153 patients treated in the UK.

  9. Budd–Chiari syndrome - Wikipedia

    en.wikipedia.org/wiki/Budd–Chiari_syndrome

    People who have paroxysmal nocturnal hemoglobinuria (PNH) appear to be especially at risk for Budd–Chiari syndrome, more than other forms of thrombophilia: up to 39% develop venous thromboses, [17] and 12% may acquire Budd–Chiari. [18]

  1. Ads

    related to: paroxysmal nocturnal hemoglobinuria pnh symptoms